National Institute of Allergy and Infectious Diseases (NIAID): all 2,445 studies

Page 20 of 25. Open to participants first (182), then studies with results posted, then the rest; newest registration first within each.

• Drug Interactions Among Anti-HIV AgentsCompletedNCT00001766Phase 1
• Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous DiseaseCompletedNCT00001765Phase 1
• Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory ConditionsCompletedNCT00001764Phase 1
• Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex InfectionCompletedNCT00001763Phase 1
• Magnetic Resonance Imaging of the Face and BonesCompletedNCT00001762
• Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's GranulomatosisCompletedNCT00001761Phase 1
• Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy IndividualsCompletedNCT00001760
• Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission TomographyCompletedNCT00001759
• Continued Antiretroviral Therapy With Abacavir, Amprenavir and EfavirenzCompletedNCT00001758Phase 2
• An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal InfectionsCompletedNCT00001757Phase 3
• Study of Mast Cell PrecursorsCompletedNCT00001756
• Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected PatientsTerminatedNCT00001651Not applicable
• Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected PatientsCompletedNCT00001650
• Valaciclovir to Prevent Transmission of Herpes Simplex VirusCompletedNCT00001649Phase 3
• Structure of the Herpes Simplex Virus ReceptorCompletedNCT00001648
• White Blood Cell Infusions to Treat HIV InfectionCompletedNCT00001647Phase 1
• Voriconazole vs. Amphotericin B in the Treatment of Invasive AspergillosisCompletedNCT00001646Phase 3
• Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV InfectionCompletedNCT00001644Phase 1
• Fluconazole Prophylaxis of Thrush in AIDSCompletedNCT00001542Phase 4
• Analysis of Bronchial Tissue and Fluid in Patients With Wegener's GranulomatosisCompletedNCT00001541
• The Use of Bacteriophage Phi X174 to Assess the Immune Competence of HIV-Infected Patients In VivoCompletedNCT00001540
• Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative VolunteersCompletedNCT00001538Phase 1
• Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to TherapyCompletedNCT00001477
• Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-upCompletedNCT00001476Phase 1
• Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor AntagonistCompletedNCT00001475Phase 2
• Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive PatientsCompletedNCT00001474Phase 2
• Cyclophosphamide and Prednisone Followed by Methotrexate To Treat VasculitidesCompletedNCT00001473
• Tissue Biopsy and Imaging Studies in HIV-Infected PatientsCompletedNCT00001471
• Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study ModificationsCompletedNCT00001409Phase 1
• Role of T-Cells in AsthmaCompletedNCT00001408
• Interferon Gamma for Drug Resistant TuberculosisCompletedNCT00001407Phase 2
• Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected PatientsCompletedNCT00001357Phase 2
• Characteristics of Mast Cells in MastocytosisCompletedNCT00001356
• Interleukin-2 Therapy for HIV Infection - Supplemental ProceduresCompletedNCT00001354Phase 2
• Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin PairsCompletedNCT00001353
• Apheresis to Obtain Plasma or White Blood Cells for Laboratory StudiesTerminatedNCT00001349
• Evaluation of HIV-Negative Patients With Low CD4+ T Lymphocyte CountsCompletedNCT00001319
• Treatment of Non-Tuberculous Mycobacterial Infections With Interferon GammaCompletedNCT00001318Phase 2
• A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of ChildhoodCompletedNCT00001317Phase 4
• A Phase I/II Study of the Combination of Azidothymidine and Interleukin-2 (IL-2) in the Treatment of HIV-Infected PatientsCompletedNCT00001282Phase 2
• Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous DiseaseCompletedNCT00001280Phase 2
• Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune ResponsesTerminatedNCT00001257
• Steroids and Methotrexate to Treat Systemic VasculitisCompletedNCT00001256Phase 2
• Study of Patients With Strongyloides Stercoralis InfectionCompletedNCT00001245
• Effects of HIV on the Development and Function of Bone Marrow CellsCompletedNCT00001243
• Studies of In Vitro B Lymphocyte Responses in Subjects Receiving Tetanus Toxoid Booster ImmunizationCompletedNCT00001173
• Clinical Investigation of Infections Due to Leishmanial ParasitesCompletedNCT00001169
• Parasitic Infections of the Gastrointestinal TractTerminatedNCT00001162
• Treatment of Wegener's Granulomatosis With CyclophosphamideCompletedNCT00001155Phase 2
• Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM SyndromeCompletedNCT00001145Phase 2
• A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV VaccineCompletedNCT00001136Phase 1
• A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their InfantsCompletedNCT00001135Phase 3
• Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or SaquinavirCompletedNCT00001133Phase 1
• Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug CombinationCompletedNCT00001132Phase 2
• Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive PatientsCompletedNCT00001131Not applicable
• Identifying Emergency Room Patients Who Have Recently Been Infected With HIVCompletedNCT00001130
• A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications CorrectlyCompletedNCT00001129Not applicable
• Treatment of Chronic Cryptosporidiosis in AIDS PatientsTerminatedNCT00001128Not applicable
• Study of a Flu Vaccine in ChildrenCompletedNCT00001127Phase 3
• Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)CompletedNCT00001126Phase 1
• Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had ChickenpoxCompletedNCT00001125Phase 1
• A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary SyndromeCompletedNCT00001123Not applicable
• A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications CorrectlyCompletedNCT00001122Phase 2
• A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1CompletedNCT00001121
• A Study of Patients With AIDS SyndromeCompletedNCT00001120
• Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIVCompletedNCT00001119Not applicable
• Study of a New Anti-HIV Drug, T-20, in HIV-Infected ChildrenCompletedNCT00001118Phase 1
• A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C InfectionCompletedNCT00001117
• A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected PatientsCompletedNCT00001116Not applicable
• The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the BloodCompletedNCT00001115Not applicable
• The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's SarcomaCompletedNCT00001114Phase 2
• A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's SarcomaCompletedNCT00001113Phase 1
• The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken ZidovudineCompletedNCT00001112Phase 1
• A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected ChildrenCompletedNCT00001111Not applicable
• Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected PatientsCompletedNCT00001110Not applicable
• A Blood Test to Look at Cells of the Immune System in Healthy ChildrenCompletedNCT00001109
• A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual DosesCompletedNCT00001108Phase 1
• Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver TransplantsCompletedNCT00001107Phase 4
• A Study of Zidovudine in HIV-Infected Pregnant Women and Their ChildrenCompletedNCT00001106Phase 1
• The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIVCompletedNCT00001105Phase 1
• A Study of Zidovudine in HIV-Infected Patients Who Have HemophiliaCompletedNCT00001104Phase 3
• HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV DrugsCompletedNCT00001103
• The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive PatientsCompletedNCT00001102
• A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme DiseaseCompletedNCT00001101Phase 3
• A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.CompletedNCT00001100Phase 3
• Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune SystemsCompletedNCT00001097
• A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected AdultsCompletedNCT00001096Phase 1
• A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken AmprenavirCompletedNCT00001095Phase 2
• A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected PatientsWithdrawnNCT00001094Phase 2
• Outcomes of Anti-HIV Therapy During Early HIV InfectionCompletedNCT00001093
• The Biology of HIV TransmissionCompletedNCT00001092
• Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and TeensCompletedNCT00001091Phase 1
• A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected VolunteersCompletedNCT00001090Phase 1
• A Study of HIV and Cytomegalovirus (CMV) in HIV-Infected PatientsCompletedNCT00001089
• A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult VolunteersCompletedNCT00001088Phase 1
• The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV DrugsCompletedNCT00001087Phase 2
• A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected PatientsCompletedNCT00001086Phase 2
• A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected PatientsCompletedNCT00001085Phase 2
• A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected PatientsCompletedNCT00001084Phase 2
• Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV DrugsCompletedNCT00001083Phase 2

← National Institute of Allergy and Infectious Diseases (NIAID) overview and focus areas